Guideline
Chimeric antigen receptor T cell therapy (CAR-T cell) - guidelines for costing, counting and reconciliation of funding
PublicationsThe guidelines set out the scope, funding, costing, counting and reconciliation of funding for the chimeric antigen receptor T cell therapy (CAR-T cell) immunotherapy program using the Novartis CAR-T product Kymriah. The CAR-T program is for paediatric and young adults...